Acadia Pharmaceuticals (ACAD.MX) Q2 2023 Earnings

8MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-4.86
-4.35
-3.85
-3.35

Details

Expected EPS
-3.7345622999999994
Actual EPS
-4.8015801
Surprise EPS
-1.07
Surprise Percent
+28.57%

Description

Acadia Pharmaceuticals (ACAD.MX) has reported earnings of -4.8015801 per share for Q2 2023.

0 Comments

Share your thoughts